» Articles » PMID: 11113952

Analysis and Design Issues for Studies Using Censored Biomarker Measurements with an Example of Viral Load Measurements in HIV Clinical Trials

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2000 Dec 13
PMID 11113952
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

For many biomarkers, the range (L,R) over which they can be quantified is restricted by technical limitations, leading to some measurements that are left or right censored. However, despite the widespread availability of statistical methods for the analysis of censored data, many studies use an imputed value for censored measurements (for example, replacing a value <L by L, or by L/2). Commonly, an analysis that ignores such imputation is then used. In clinical trials, this leads to bias and a loss of power in evaluating treatment effects. In this paper, a review of appropriate statistical methods for parametric and non-parametric analysis of such measurements is presented. This includes methods for situations in which baseline measurements are available. New results concerning design issues such as sample size determination are also presented. The paper is illustrated using two examples of studies that included censored measurements of viral load in HIV-infected subjects.

Citing Articles

Maternal characteristics are associated with human milk anti-inflammatory proteins in two populations.

Miller E Sci Rep. 2024; 14(1):30941.

PMID: 39730549 PMC: 11681199. DOI: 10.1038/s41598-024-81806-z.


Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.

Moser C, Chew K, Giganti M, Li J, Aga E, Ritz J J Infect Dis. 2023; 228(Suppl 2):S101-S110.

PMID: 37650235 PMC: 10469328. DOI: 10.1093/infdis/jiad285.


Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.

Moser C, Chew K, Giganti M, Li J, Aga E, Ritz J medRxiv. 2023; .

PMID: 36993419 PMC: 10055451. DOI: 10.1101/2023.03.13.23287208.


A family of estimators to diagnostic accuracy when candidate tests are subject to detection limits-Application to diagnosing early stage Alzheimer disease.

Xiong C, Luo J, Agboola F, Grant E, Morris J Stat Methods Med Res. 2022; 31(5):882-898.

PMID: 35044258 PMC: 9018582. DOI: 10.1177/09622802211072511.


Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue.

Gholiha A, Hollander P, Lof L, Larsson A, Hashemi J, Ulfstedt J Cancers (Basel). 2022; 14(1).

PMID: 35008176 PMC: 8750205. DOI: 10.3390/cancers14010009.